Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities, calculated as total liabilities divided by total asset. Ingevity's Total Liabilities for the quarter that ended in Jun. 2026 was MXN26,009 Mil. Ingevity's Total Assets for the quarter that ended in Jun. 2026 was MXN26,828 Mil.
Therefore, Ingevity's Liabilities-to-Assets Ratio for the quarter that ended in Jun. 2026 was 0.97.
Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.
Ingevity Liabilities-to-Assets Related Terms
Ingevity Liabilities-to-Assets Historical Data
* Premium members only.
The historical data trend for Ingevity's Liabilities-to-Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:NGVT vs CC, KWR, MTX: Liabilities-to-Assets Comparison
For the Specialty Chemicals subindustry, Ingevity's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ingevity Liabilities-to-Assets vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Ingevity's Liabilities-to-Assets distribution charts can be found below:
* The bar in red indicates where Ingevity's Liabilities-to-Assets falls into.
Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.
Ingevity's Liabilities-to-Assets Ratio for the fiscal year that ended in Dec. 2025 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ingevity (MEX:NGVT) has a Liabilities-to-Assets of 0.97 as of Jun. 2026. Liabilities-to-Assets equals total liabilities divided by total assets. It measures financial leverage. View historical data on Ingevity and its competitors.
Is Ingevity's Liabilities-to-Assets too high?
Ingevity's current Liabilities-to-Assets is 0.97. Overall, Ingevity has a GF Score™ of 62/100, reflecting its overall financial health beyond just this single metric.
How does Ingevity's Liabilities-to-Assets compare to CC and KWR?
Ingevity's Liabilities-to-Assets of 0.97 can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Liabilities-to-Assets for a Chemicals company?
A good Liabilities-to-Assets depends on the Chemicals industry context. However, Liabilities-to-Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Liabilities-to-Assets mean?
A high Liabilities-to-Assets can signal that a stock is expensive relative to its fundamentals. Liabilities-to-Assets equals total liabilities divided by total assets. It measures financial leverage. View historical data on Ingevity and its competitors. Ingevity's current Liabilities-to-Assets is 0.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ingevity stock overvalued right now?
Ingevity (MEX:NGVT) has a current Liabilities-to-Assets of 0.97. The stock's GF Value™ is MXN936.97, compared to a current price of MXN1,430.00 — trading 52.6% above its estimated fair value. The current Liabilities-to-Assets is 0.97. Ingevity's overall GF Score™ is 62/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Liabilities-to-Assets calculated?
Liabilities-to-Assets is calculated from a company's financial statements. For Ingevity (MEX:NGVT), the current Liabilities-to-Assets is 0.97 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ingevity (MEX:NGVT) Overvalued in 2026?
Based on GuruFocus' analysis, Ingevity stock appears to be overvalued.
The current stock price of MXN1,430.00 is trading 52.6% above its estimated GF Value™ of MXN936.97.
Key valuation signals for MEX:NGVT:
Liabilities-to-Assets: 0.97
GF Value™: MXN936.97 vs. price of MXN1,430.00 (52.6% above fair value)
No single metric tells the full story. See the MEX:NGVT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through three segments, namely Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals that find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focuses on automotive carbon products used in automobiles. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers. The company generates the majority of its revenue from North America.
62GF Score
Get the complete analysis for MEX:NGVT
Liabilities-to-Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:NGVT has been successfully added to your 
